Identification of cembratriene-4,6-diol as antitumor-promoting agent from cigarette smoke condensate

Publisher Website
Google Scholar
Abstract
Cigarette smoke condensate (CSC) was separated into several fractions and each was tested for an inhibitory effect on the early antigen (EA) of Epstein-Barr virus (EBV) which can be induced by 12-0-tetradecanoylphorbol-13-acetate (TPA) in Raji cells. Two diastereoisomers of 2,7,11-cembratriene-4,6-diol (α- and β-CBT) were isolated from the neutral fractions of CSC and these showed potent inhibitory effects on the induction of EBV-EA by TPA. The doses of α- and β-CBT required for 50% inhibition of EBV-EA induction by TPA were 7.7 and 6.7 μg/ml, respectively, which are comparable with those of retinoic acid, a potent inhibitor of induction of epideral ornithine decarboxylase (ODC) activity and tumor promotion by TPA in mice. Application of α- and β-CBT to mouse skin prior to treatment with TPA inhibited TPA-induced ODC activity. The degree of inhibition was dependent on the dose and application of 16.5 μmol/mouse of α- and β-CBT resulted in a 50 and 40% reduction, respectively, of the maximum of the ODC activity induced as a result of treatment with TPA. In initiation-promotion experiments, α-CBT markedly inhibited the promoting effect of TPA on skin tumor formation in mice which were initiated with 7,12-dimethylbenz[a]anthracene, but β-CBT was found to be less effective. Application of 3.3 μmol of α-CBT 40 min prior to treatment with TPA (1 μg) resulted in a 53% reduction in the number of papillomas per mouse. Our present data suggest that EBV-EA inhibition assay using Raji cells is effective for the first screening of inhibitors of tumor promotion, and provide evidence that CSC contains antitumor-promoting agents in addition to carcinogenic and tumor-promoting agents already reported.

This publication has 19 references indexed in Scilit: